Neurology News

Children born to mothers who used triptans for their migraines during pregnancy did not have a greater risk for ADHD symptoms or diagnosis at 5 years of age, according to a Norwegian registry-based study.

DENVER — Verapamil was shown to be tolerable for migraine prevention at a maximum dose of 20 mg to 480 mg per day, Yi-Chieh Chen, PharmD, said at the American Headache Society’s annual scientific meeting.

A sensor-equipped computer program was nearly 80% effective in identifying and counting arm movements in patients undergoing stroke rehabilitation, researchers from NYU Grossman School of Medicine announced.

In this week’s edition, CAR-T ‘robustly effective’ in younger patients with deadly form of brain cancer; SARS-CoV-2 linked to range of neurological diseases; Increased mortality risk for men with type 1 diabetes, regardless of cognitive ability; and more.

DENVER — A child’s understanding of a migraine may not align with diagnostic criteria, highlighting the need for greater transparency in defining “migraine day,” Danielle Kellier, BS, said at the American Headache Society’s annual meeting.

DENVER — Although migraine prevalence has remained stable over the past 30 years, measures of burden, including MIDAS scores, have steadily increased, Fred Cohen, MD, said at the American Headache Society’s annual scientific meeting.

DENVER — In this Healio video, Jessica Ailani, MD, explains that patient selection for clinical trials is not a one-size-fits-all process.

DENVER — Nerivio, a noninvasive digital therapeutic device, provided migraine pain relief within 2 hours in 67% of adults and 71% of adolescents, Alon Ironi said at the American Headache Society’s annual scientific meeting.

Those diagnosed with dementia faced a greater risk for COVID-19 breakthrough infections and hospitalizations than those without, according to a study published in Alzheimer’s & Dementia.

The FDA has approved Amvuttra, an RNA interference therapeutic for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults.